The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,274.00
Bid: 1,268.00
Ask: 1,276.00
Change: 6.00 (0.47%)
Spread: 8.00 (0.631%)
Open: 1,298.00
High: 1,298.00
Low: 1,242.00
Prev. Close: 1,268.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and Q1 Interim Management Statement

6 Feb 2019 07:00

RNS Number : 1777P
Victrex PLC
06 February 2019
 
 

 

6 February 2019

Victrex plc

AGM and Q1 Interim Management Statement

'Weaker 1st quarter, but H2 opportunity unchanged and continued progress in future growth projects'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its first quarter (Q1) Interim Management Statement ahead of its Annual General Meeting (AGM) being held today.

With expected end-market headwinds, tougher comparatives, some de-stocking and adverse currency, Victrex saw a weaker start to its 2019 financial year. Overall, Q1 revenue of £64.1m was 18% down on the prior year (Q1 2018: £78.7m), with Q1 Group sales volume of 822 tonnes being 22% down on the prior year (Q1 2018: 1,051 tonnes). Excluding volumes for the large Consumer Electronics contract, core business volumes were down approximately 13% during Q1.

Q1 headwinds were predominantly in Automotive and Consumer Electronics markets, principally the ongoing slowdown in Automotive and the associated impact on Value Added Resellers, which sees volumes indirectly supplied to Automotive. As expected, Q1 also saw no volumes supplied for the Large Consumer electronics contract, versus a strong comparative last year.

Pleasingly, January and February saw an improvement, with a notable pick-up in Automotive sales.

Mega-programmes

Our pipeline of new products remains strong. In Gears, we passed advanced prototyping with a major global car manufacturer, ahead of a second, and larger, supply agreement for PEEK based Gears. This opportunity is expected to start in the second half. Whilst cars and light vehicles remain the focus, we have opportunities for PEEK Gears in other modes of transport, with two smaller supply agreements now in place. In our Medical mega-programmes, following submission of the clinical trial for the Knee programme, our partner Maxx Orthopedics is now ready to commence patient recruitment.

Investments for growth

Victrex made two small investments during the period, supporting development of our Polymer & Parts strategy. A small equity investment was made in UK-based Surface Generation Limited, to form a partnership utilising potentially state of the art manufacturing processes, which will support Victrex's mega programmes. The PtFS (Production to Functional Specification) technology offers the potential for enhanced manufacturing effectiveness beyond standard moulding technology, including driving reductions in energy consumption and cycle times required to process the most complex material and part combination.

The Group has also invested in Bond 3D High Performance Technology BV, a Dutch company developing unique, protectable 3D printing (Additive Manufacturing) processes which are capable of producing high strength parts from existing grades of PEEK and PAEK polymers. The investment offers the potential of utilising this technology to help accelerate the market adoption of 3D printed PEEK parts, with particular emphasis on the Medical market.

Financial position

Victrex retains a highly cash generative business model, with no change to its financial position since 30 September 2018. Currency, raw material and energy cost inflation remain modest headwinds for 2019, although these will fall predominantly in the first half.

Outlook

Jakob Sigurdsson, Chief Executive of Victrex, said: "Although Q1 is always the seasonally weakest quarter for Victrex, this quarter has been slightly weaker than anticipated, driven principally by the slowdown in Automotive, the associated impact on Value Added Resellers, and some de-stocking. Q1 also saw expected headwinds in Consumer Electronics, together with strong comparatives and adverse currency.

Pleasingly, January and February saw some initial improvement, although given our Q1 performance, the first half is expected to be much weaker overall, compared to the prior year. Our expectations for the second half are unchanged, with new projects and reduced headwinds supporting our assumptions. With strong structural growth opportunities, a healthy new product pipeline and a highly cash generative business model, we continue to be well-placed for the medium and long term."

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications +44 (0) 7809 595831

Richard Armitage, Group Finance Director +44 (0) 1253 897700

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

 

Analyst and investor call:

A conference call for analysts and investors will be held this morning at 08.30am GMT. Dial in details +44 (0) 3333 000804 PIN: 49486973#

 

Annual General Meeting:

Victrex will hold its Annual General Meeting at 11.00am this morning, at the offices of JP Morgan Cazenove, 1 John Carpenter Street, London, EC4Y 0JP.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTTAMMTMBBMTBL
Date   Source Headline
30th Apr 202011:39 amRNSTotal Voting Rights
17th Apr 202012:04 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSMarket Update
3rd Apr 20207:00 amRNSDirector Declaration
31st Mar 20209:22 amRNSTotal Voting Rights
24th Mar 20202:00 pmRNSDirectorate Change
17th Mar 20203:32 pmRNSHolding(s) in Company
17th Mar 20202:52 pmRNSDirector/PDMR Shareholding
16th Mar 202010:05 amRNSHolding(s) in Company
12th Mar 202012:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20209:49 amRNSDirector/PDMR Shareholding
28th Feb 202011:56 amRNSTotal Voting Rights
20th Feb 20204:50 pmRNSDirector/PDMR Shareholding
13th Feb 20201:59 pmRNSDirector/PDMR Shareholding
6th Feb 20202:34 pmRNSDirector/PDMR Shareholding
6th Feb 20201:20 pmRNSResult of AGM
6th Feb 202010:54 amRNSDirector/PDMR Shareholding
6th Feb 20207:00 amRNSAGM and Q1 Interim Management Statement
5th Feb 20204:22 pmRNSHolding(s) in Company
4th Feb 20203:42 pmRNSHolding(s) in Company
31st Jan 202010:39 amRNSTotal Voting Rights
20th Jan 202010:04 amRNSDirector/PDMR Shareholding
17th Jan 202010:38 amRNSDirector/PDMR Shareholding
13th Jan 20204:06 pmRNSHolding(s) in Company
13th Jan 20208:46 amRNSJoint Venture
3rd Jan 202012:00 pmRNSAnnual Financial Report
31st Dec 20199:00 amRNSTotal Voting Rights
23rd Dec 20191:44 pmRNSHolding(s) in Company
17th Dec 20192:20 pmRNSDirector/PDMR Shareholding
12th Dec 201910:04 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSPreliminary Results 2019
2nd Dec 20191:52 pmRNSBlock listing Interim Review
29th Nov 201911:38 amRNSTotal Voting Rights
19th Nov 201911:02 amRNSDirector/PDMR Shareholding
12th Nov 201912:00 pmRNSDirectorate Change
31st Oct 201911:36 amRNSTotal Voting Rights
28th Oct 20191:41 pmRNSHolding(s) in Company
18th Oct 20194:01 pmRNSHolding(s) in Company
18th Oct 20192:20 pmRNSDirector/PDMR Shareholding
16th Oct 201911:04 amRNSAdditional Listing
11th Oct 20194:18 pmRNSHolding(s) in Company
8th Oct 20193:09 pmRNSHolding(s) in Company
7th Oct 20194:06 pmRNSHolding(s) in Company
3rd Oct 20194:18 pmRNSHolding(s) in Company
30th Sep 201911:53 amRNSTotal Voting Rights
18th Sep 20199:19 amRNSDirector/PDMR Shareholding
30th Aug 20199:00 amRNSTotal Voting Rights
19th Aug 201911:44 amRNSDirector/PDMR Shareholding
14th Aug 201910:39 amRNSHolding(s) in Company
31st Jul 20199:01 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.